The purpose of this study was to evaluate women who have completed hereditary cancer risk assessment and BRCA genetic testing to determine if they considered themselves prepared to proceed with decision making regarding cancer screening and prevention options. Levels of decisional conflict were explored, as was their preference for information delivery. The prospective, descriptive survey was conducted at a breast and clinical genetics clinic at a comprehensive cancer center in the northeastern United States. Twenty-seven female participants completed the Preparation for Decision Making scale, Decisional Conflict Scale, and a demographic questionnaire. Scores were consistent with high levels of preparation for decision making and low decisional conflict. The face-to-face approach was the preferred method for information delivery. Subgroup analysis demonstrated a difference in the measured objectives based on cancer status but not based on BRCA status. The current information delivery approach is meeting the decision-making needs of women considered to be at increased risk for hereditary breast and ovarian cancer.
American Cancer Society. (2013). American Cancer Society recommendations for early breast cancer detection in women without breast symptoms. Retrieved from <a target="_blank" href='http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerea...
Bennett, C., Graham, I.D., Kristjansson, E., Kearing, S.A., Clay, K.F., & O'Connor, A.M. (2010). Validation of a preparation for decision making scale. <i>Patient Education and Counseling, 78</i>, 130-133. doi:10.1016/j.pec.2009.05.012
Chen, S., & Parmigiani, G. (2007). Meta-analysis of BRCA1 and BRCA2 penetrance. <i>Journal of Clinical Oncology, 25</i>, 1329-1333.
Chick, N., & Meleis, A.I. (1986). Transitions: A nursing concern. In P.L. Chinn (Ed.), <i>Nursing research methodology: Issues and implementations</i> (pp. 237-257). Boulder, CO: Aspen.
Claus, E.B., Risch, N., & Thompson, W.D. (1994). Autosomal dominant inheritance of early-onset breast cancer. <i>Cancer, 73</i>, 643-651. doi:10.1002/1097-0142(19940201)
Fisher, B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., … Wolmark, N. (1998). Tamoxifen for the prevention of breast cancer: Report from the National Surgical Adjuvant Breast and Bowel Project P-1 study. <i>Journal of the National Cancer Institute, 90</i>, 1371-1388.
Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., Green, S.B., Schairer, C., & Mulvihill, J.J. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. <i>Journal of the National Cancer Institute, 81</i>, 1879-1886.
Graham, I.D., & O'Connor, A.M. (1995). <i>User manual-Preparation for decision making.</i> Retrieved from http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_PrepDM.pdf <a target="_blank" href='http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_PrepDM.pdf'>http...
Hack, T.F., Degner, L.F., Watson, P., & Sinha, L. (2006). Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. <i>Psycho-Oncology, 15</i>, 9-19. doi:10.1002/pon.907
Hall, J.M., Lee, M.K., Newman, B., Morrow, J.E., Anderson, L.A., Huey, B., & King, M.C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. <i>Science, 250</i>, 1684-1689. doi:10.1126/science.2270482
Hamilton, R.J., Bowers, B.J., & Williams, J.K. (2005). Disclosing genetic test results to family members. <i>Journal of Nursing Scholarship, 37</i>, 18-24. doi:10.1111/j.1547-5069.2005.00007.x
Hoogerbrugge, N., Kamm, Y.J., Bult, P., Landsbergen, K.M., Bongers, E.M., Brunner, H.G., … Boetes, C. (2008). The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. <i>Annals of Oncology, 19</i>, 655-659. doi:10.1093/annonc/mdm537
Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S.F., … Cronin, K.A. (2013). SEER Cancer Statistics Review, 1975-2010. Retrieved from <a target="_blank" href='http://seer.cancer.gov/csr/1975_2010'>http://seer.cancer.gov/csr/1975_20...
Institute of Medicine. (2001). <i>Crossing the quality chasm: A new health system for the 21st century.</i> Washington, DC: National Academies Press.
Meleis, A.I., Sawyer, L.M., Im, E.O., Hilfinger Messias, D.K., & Schumacher, K. (2000). Experiencing transitions: An emerging middle-range theory. <i>Advances in Nursing Science, 23</i>, 12-28.
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., … Ding, W. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. <i>Science, 266</i>(7), 66-71. doi:10.1126/science.7545954
Narod, S.A., & Offit, K. (2005). Prevention and management of hereditary breast cancer. <i>Journal of Clinical Oncology, 22</i>, 1656-1663. doi:10.1200/JCO.2005.10.035
Nelson, H.D., Huffman, L.H., Fu, R., & Harris, E.L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Task Force. <i>Annals of Internal Medicine, 143</i>, 362-379. doi:10.7326/0003-4819-143-5-200509060-00011
O'Connor, A.M. (1993). User manual-Decisional conflict scale. Retrieved from <a target="_blank" href='http://decisionaid.ohri.ca/docs/develop/User_Manuals/UM_Decisional_Confl...
O'Connor, A.M. (1995). Validation of a decisional conflict scale. <i>Medical Decision Making, 15</i>, 25-30.
O'Connor, A., Jacobsen, M.J., Elmsie, T., Jolly E., Wells, G., Bunn, H., … Tugwell, P. (2000). Simple vs. complex patient decision aids: Is more necessarily better? <i>Medical Decision Making, 20</i>, 496.
Petrucelli, N., Daly, M., & Feldman, G. (2011). BRCA1 and BRCA2 hereditary breast and ovarian cancer. Retrieved from <a target="_blank" href='http://www.ncbi.nlm.nih.gov/books/NBK1247'>http://www.ncbi.nlm.nih.gov/b...
Pierce, P.F. (1993). Deciding on breast cancer treatment: A description of decision behavior. <i>Nursing Research, 42</i>, 22-28.
Stacey, C.D., O'Connor, A.M., DeGrasse, C., & Verma, S. (2003). Development and evaluation of a breast cancer prevention decision aid for higher risk women. <i>Health Expectations, 6</i>, 3-18.
U.S. Department of Health and Human Services. (2012). Preventive services covered under the Affordable Care Act. Retrieved from <a target="_blank" href='http://www.hhs.gov/healthcare/facts/factsheets/2010/07/preventive-servic...
Velicer, C.M., & Taplin, S. (2001). Genetic testing for breast cancer: Where are health care providers in the decision process? <i>Genetics in Medicine, 3</i>, 112-119.
Wilson, B.J., Forrest, K., van Teijlingen, E.R., McKee, L., Haites, N., Matthews, E., & Simpson, S.A. (2004). Family communication about genetic risk: The little that is known. <i>Community Genetics, 7</i>, 15-24. doi.org/10.1159/000080300
Wooster, R., Neuhausen, S.L., Mangion, J., Quirk, Y., Ford, D., Collins, N., … Averill, D. (1994). Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. <i>Science, 265</i>, 2088-2090. doi:10.1126/science.8091231